ALR Technologies SG Ltd. (ALRTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0125
+0.0016 (14.68%)
Jul 11, 2025, 4:00 PM EDT
ALR Technologies SG Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
8.07M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
ALR Technologies SG News
- 18 days ago - ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM - PRNewsWire
- 1 year ago - ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study - PRNewsWire
- 2 years ago - ALR Technologies Announces Canadian Launch Plans for the GluCurve Pet CGM - GlobeNewsWire
- 2 years ago - ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs - GlobeNewsWire
- 2 years ago - Covetrus To Showcase Innovation and Technology at VMX 2023 - PRNewsWire
- 2 years ago - UPDATE: ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement - GlobeNewsWire
- 2 years ago - ALR Technologies Announces Co-branded Distribution Partnership with Covetrus for GluCurve Pet CGM, the First Continuous Glucose Monitoring System for Diabetic Pets - Newsfile Corp